Article published by three of our Community members in AAPS Open!
"Stability considerations for drug-device combination products - 21 CFR part 4 update"
by Christopher Latoz, Laure Larkin, and Kim Huyhn-Ba
Stability Considerations for Drug-Device Combination Products
------------------------------
Lori McCaig
Director Global Stability Program Management
Seagen, Inc.
San Jose CA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------